• #24: US Pharma and Life Sciences Deals: 2025

  • Feb 19 2025
  • Length: 13 mins
  • Podcast

#24: US Pharma and Life Sciences Deals: 2025

Listen for free

View show details

  • Summary

  • The pharmaceutical and life sciences sector anticipates a surge in merger and acquisition activity in 2025. Driving this trend are expected interest rate reductions by the Federal Reserve and the resolution of post-election uncertainties. While deal values and volumes are projected to rise, transactions in the $5 billion to $15 billion range are forecasted to be the most common. However, geopolitical issues could present obstacles to this growth.





    Hosted on Acast. See acast.com/privacy for more information.
    Show more Show less
Show more Show less

What listeners say about #24: US Pharma and Life Sciences Deals: 2025

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available